Program Description

Symposium Description

The symposium is an overview of the current and emerging technologies that are changing the patterns of practice and moving towards personalized medicine. The approach is to discuss the impact of the new molecular testing on several disciplines such as genetics, cancer, infectious diseases, metabolic disorders, pharmacogenetics, and aging.

The target audience includes physicians in the many disciplines involved in diagnoses, treatment and management of cancer, infectious and other diseases, who are interested in an update on the latest evidence-based research and technological advances in molecular medicine.

Objectives

Upon completion of this course, participants should be able to:

Identify comprehensive diagnostic technologies for use in early detection of cancers such as cervical cancer, leukemia, and the vaccine for cervical cancer.
Describe methodology for earlier detection of lower concentrations of target organisms for HIV, HPV, HCV, hepatitis B and C and other infectious diseases.
Discuss emerging role of molecular genetic testing in developing predictive values when screening for disease-associated genetic mutations in cervical and other cancers.
Recognize the emergence of promising new molecular-targeted agents and new technologies for screening and early detection which provide new opportunities for applying clinical trial designs that integrate therapy and prevention end points.
Explore the role of current and future treatment strategies for posttransplant lymphoproliferative disorder (PTLD).
Compare results of studies that suggest genetic polymorphisms may contribute to variability in responses to beta-blockers and discuss the potential implications of beta-blocker pharmacogenetics in clinical practice.
Describe clinical trials that demonstrate the importance of pre-therapeutic genotyping to identify the subjects likely to develop undesirable drug effects.
Compare emerging role of molecular-targeted therapy with the role of Herceptin® in changing treatment guidelines for women with early breast cancer who carry the HER2/neu gene.

CME Accreditation

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this educational activity for a maximum of 16 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Special Assistance

The resort is aware of and agrees to abide by the guidelines of the Americans with Disabilities Act. In the event that you have any special requests or needs, please advise the resort immediately so that we may address any concerns.

Location

With an exclusive address inside the WALT DISNEY WORLD® Resort, the Buena Vista Palace and the surrounding area offer an enticing variety of opportunities and attractions.

Soaring 27 stories above the world’s greatest destination, the Buena Vista Palace is located in the heart of the shops and restaurants, exhilarating nighttime fun and dazzling entertainment options of the DOWNTOWN DISNEY® Marketplace, Pleasure Island and West Side, Four Disney Theme Parks and two water parks are a quick, complimentary shuttle ride away.

In addition to all the Disney attractions, Buena Vista Palace guests can enjoy preferred tee times at the five WALT DISNEY WORLD® championship golf courses. Also nearby are the Disney Wide World of Sports® Complex and Orlando Arena for sports fans, beautiful Cocoa Beach for sun lovers and world-class malls and designer outlets for shopping enthusiasts.

Travel

Lorraine Travel Bureau, Inc. has been selected as the official travel agency for the symposium. Lorraine Travel is offering special meeting fares on round-trip travel to the symposium. Symposium participants may obtain further details on discounted airfares by calling Ms. Chanel Cerqueira at Lorraine Travel at 1-877-844-7977 or by email at chanel@lorrainetravel.com. Please be sure to mention “Molecular Medicine: Applying Current and Emerging Technologies” when you call.

From Orlando International Airport: From the north end of the airport, take SR-528 (Beachline Expressway toll road) heading west. Merge onto I-4 West. From I-4, take Exit #68, then turn right onto SR-535. Turn left onto Hotel Plaza Boulevard, then right onto E. Buena Vista Drive. Hotel is on the right. Travel to and from the airport is the responsibility of the participant.

Registration Fee

Advanced registration is requested NO LATER THAN FEBRUARY 21, 2008. Please complete the attached registration form and mail with your check made payable to "University of Florida." The registration fees are as follows:

   by February 21, 2008				

Physicians		$ 300.00
Non-Physicians 	$ 150.00
Residents 		$ 100.00


 After February 21, 2008

Physicians		$ 350.00
Non-Physicians 	$ 200.00
Residents 		$ 150.00

Conference materials, breakfasts, lunches, and breaks are included in the registration fees (for participants only).

Refund Policy

A full refund will be given for written cancellations received on or before February 21, 2008. Refunds after this date and up to March 4, 2008 will be subject to a $50.00 processing fee. NO REFUNDS WILL BE GIVEN AFTER MARCH 4, 2008, but substitutions are allowed with advance notice. In the event of postponement or cancellation, a full registration refund will be given. The University of Florida is not responsible for any related costs or expenses including cancellation or change in charges assessed by the airlines.